Related Experiment Video
Updated: Sep 27, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4
Xia Lin1, Min Liang, Yao-Yun Liang
1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA.
Abstract:
Smads are important intracellular effectors in signaling pathways of the transforming growth factor-beta (TGF-beta) superfamily. Upon activation by TGF-beta, receptor-phosphorylated Smads form a complex with tumor suppressor Smad4/DPC4, and the Smad complexes then are imported into the nucleus. Although diverse pathways regulate the activity and expression of receptor-phosphorylated and inhibitory Smads, cellular factors modulating the activity of the common Smad4 remain unidentified. Here we describe the involvement of the small ubiquitin-like modifier-1 (SUMO-1) conjugation pathway in regulating the growth inhibitory and transcriptional responses of Smad4. The MH1 domain of Smad4 was shown to associate physically with Ubc9, the ubiquitin carrier protein (E2) conjugating enzyme in sumoylation. In cultured cells, Smad4 is modified by SUMO-1 at the endogenous level. The sumoylation sites were identified as two evolutionarily conserved lysine residues, Lys-113 and Lys-159, in the MH1 domain. We found that the mutations at Lys-113 and Lys-159 did not alter the ability of Smad4 to form a complex with Smad2 and FAST on the Mix.2 promoter. Importantly, SUMO-1 overexpression enhanced TGF-beta-induced transcriptional responses. These findings identify sumoylation as a unique mechanism to modulate Smad4-dependent cellular responses.
Insights
Small ubiquitin-like modifier-1 (SUMO-1) conjugation regulates Smad4 activity. Sumoylation enhances transforming growth factor-beta (TGF-beta)-induced cellular responses, identifying a novel regulatory mechanism for Smad4.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Smads are key intracellular mediators in transforming growth factor-beta (TGF-beta) superfamily signaling.
- Activated Smads complex with Smad4 and translocate to the nucleus.
- Factors regulating Smad4 activity are largely unknown.
Purpose of the Study:
- To investigate the role of small ubiquitin-like modifier-1 (SUMO-1) conjugation in modulating Smad4 function.
- To identify the mechanism by which Smad4 activity is regulated.
Main Methods:
- Investigated the physical interaction between Smad4 and Ubc9 (E2 conjugating enzyme).
- Assessed Smad4 modification by SUMO-1 in cultured cells.
- Identified sumoylation sites (Lys-113 and Lys-159) within the Smad4 MH1 domain.
- Utilized site-directed mutagenesis to evaluate the impact of sumoylation on Smad4 complex formation and transcriptional activity.
Main Results:
- Smad4 physically associates with Ubc9, the key enzyme in sumoylation.
- Smad4 undergoes SUMO-1 modification at endogenous levels.
- Mutations at Lys-113 and Lys-159 did not impair Smad4 complex formation with Smad2 and FAST on the Mix.2 promoter.
- Overexpression of SUMO-1 potentiated TGF-beta-induced transcriptional responses.
Conclusions:
- Sumoylation is a novel mechanism regulating Smad4 activity.
- SUMO-1 conjugation enhances Smad4-dependent growth inhibitory and transcriptional responses.
- This study elucidates a new pathway for controlling TGF-beta signaling via Smad4 modification.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
09:00Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway